Skip to main content
    • Aa
    • Aa
  • The International Journal of Neuropsychopharmacology, Volume 13, Issue 10
  • November 2010, pp. 1285-1298

F15599, a highly selective post-synaptic 5-HT1A receptor agonist: in-vivo profile in behavioural models of antidepressant and serotonergic activity


F15599 is a novel agonist with high selectivity and efficacy at serotonin 5-HT1A receptors (5-HT1ARs). In signal transduction, electrophysiological and neurochemical tests, F15599 preferentially activates post-synaptic 5-HT1ARs in rat frontal cortex. Such a profile may translate to an improved profile of therapeutic activity for mood disorders. The in-vivo effects of F15599 were therefore compared with those of a related compound, F13714, in rat models of antidepressant activity and 5-HT1AR activation: forced swimming test (FST), conditioned stress-induced ultrasonic vocalization, 5-HT syndrome, plasma corticosterone and body temperature. Acute administration of F15599 or F13714 reduced immobility in the FST at low doses; these effects were long lasting and the effects of F15599 were maintained after repeated (5 d, p.o.) administration. Both compounds decreased ultrasonic vocalization duration at low doses. In contrast, higher doses of F15599 were required to induce lower lip retraction, elements of the 5-HT behavioural syndrome, hypothermia and to increase plasma corticosterone levels. Notably, there was a greater separation of ED50 between FST and other effects for F15599 than for F13714. Thus, the in-vivo potency of F15599 in models of antidepressant/anti-stress activity is similar to that of F13714, despite the fact that the latter has an in-vitro potency two orders of magnitude greater. In contrast F15599 has a lower propensity than F13714 to induce other serotonergic signs. The distinctive pharmacological profile of F15599 suggests that preferential targeting of post-synaptic 5-HT1ARs constitutes a promising strategy for improved antidepressant therapy.

Corresponding author
Address for correspondence: Dr A. Newman-Tancredi, Neurobiology II Division, Centre de Recherche Pierre Fabre, 17 avenue Jean Moulin, 81106Castres Cedex, France. Tel.: +33563 714 269Fax: +33 563 714 363Email:
Linked references
Hide All

This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.

F Artigas , A Adell , P Celada (2006). Pindolol augmentation of antidepressant response. Current Drug Targets 7, 139147.

M-B Assié , L Bardin , R Depoortère , E Carilla-Durand , A Newman-Tancredi (2006 a). F15599, a highly selective serotonin 5-HT1A receptor agonist: in vivo profile in neurochemical and behavioural models of serotonergic activity. European Neuropsychopharmacology 16 (Suppl. 4), S233.

M-B Assié , H Lomenech , V Ravailhe , V Faucillon , (2006 b). Rapid desensitization of somatodendritic 5-HT1A receptors by chronic administration of the high-efficacy 5-HT1A agonist, F13714: a microdialysis study in the rat. British Journal of Pharmacology 149, 170178.

L Bardin , S Gregoire , M Aliaga , N Malfetes , (2009). Comparison of milnacipran, duloxetine and pregabalin in the formalin pain test and in a model of stress-induced ultrasonic vocalizations in rats. Neuroscience Research. Published online: 1 October 2009. doi:10.1016/j.neures.2009.10.009.

HHG Berendsen , FGM Bourgondien , CLE Broekkamp (1994). Role of dorsal and median raphe nuclei in lower lip retraction in rats. European Journal of Pharmacology 263, 315318.

HHG Berendsen , F Jenck , CL Broekkamp (1989). Selective activation of 5HT1A receptors induces lower lip retraction in the rat. Pharmacology, Biochemistry and Behavior 33, 821827.

Z Bhagwagar , EA Rabiner , PA Sargent , PM Grasby , (2004). Persistent reduction in brain serotonin1A receptor binding in recovered depressed men measured by positron emission tomography with [11C]WAY-100635. Molecular Psychiatry 9, 386392.

KC Bicego , RC Barros , LG Branco (2007). Physiology of temperature regulation: comparative aspects. Comparative Biochemistry and Physiology, Part A 147, 616639.

P Blier , NM Ward (2003). Is there a role for 5-HT1A agonists in the treatment of depression? Biological Psychiatry 53, 193203.

J Buritova , G Berrichon , C Cathala , FC Colpaert , (2009). Region-specific changes in 5-HT1A agonist-induced extracellular signal-regulated kinases 1/2 phosphorylation in rat brain: a quantitative ELISA study. Neuropharmacology 56, 350361.

AE Calogero , G Bagdy , K Szemeredi , ME Tartaglia , (1990). Mechanisms of serotonin receptor agonist-induced activation of the hypothalamic–pituitary–adrenal axis in the rat. Endocrinology 126, 18881894.

P Celada , L Llado , M-B Assié , A Newman-Tancredi , (2007). F15599, a 5-HT1A agonist that preferentially targets post-synaptic receptors in the frontal cortex: (IV) Influence on rat raphe and pyramidal neuronal activity and cortical dopamine release. 2007 Neuroscience Meeting Planner. San Diego, CA: Society for Neuroscience, 2007. Online. 170.27.

P Celada , M Puig , M Amargós-Bosch , A Adell , (2004). The therapeutic role of 5-HT1A and 5-HT2A receptors in depression. Journal of Psychiatry and Neuroscience 29, 252265.

FC Colpaert , W Koek , J Lehmann , JM Rivet , (1992). S-14506 – a novel, potent, high-efficacy 5-HT1A agonist and potential anxiolytic agent. Drug Development Research 26, 2148.

JC Compaan , L Groenink , J Van der Gugten , RAA Maes , (1997). Pretreatment with 5-HT1A receptor agonist flesinoxan attenuates Fos protein in rat hypothalamus. European Journal of Pharmacology 324, 161168.

JF Cryan , P Kelliher , JP Kelly , BE Leonard (1999). Comparative effects of serotonergic agonists with varying efficacy at the 5-HT1A receptor on core body temperature: modification by the selective 5-HT1A receptor antagonist WAY 100635. Journal of Psychopharmacology 13, 278283.

J De Vry (1995). 5-HT1A receptor agonists: recent developments and controversial issues. Psychopharmacology 121, 126.

J De Vry , R Schreiber (1993). Comparison of acute and repeated treatment with the 5-HT1A receptor ligands 8-OH-DPAT and ipsapirone in animal models of anxiety and depression. Drug Development Research 30, 91–103.

J De Vry , R Schreiber , C Melon , M Dalmus , (2004). 5-HT1A receptors are differentially involved in the anxiolytic- and antidepressant-like effects of 8-OH-DPAT and fluoxetine in the rat. European Neuropsychopharmacology 14, 487495.

MJ Detke , S Wieland , I Lucki (1995). Blockade of the antidepressant-like effects of 8-OH-DPAT, buspirone and desipramine in the rat forced swim test by 5HT1A receptor antagonists. Psychopharmacology 119, 4754.

WC Drevets , E Frank , JC Price , DJ Kupfer , (1999). PET imaging of serotonin 1A receptor binding in depression. Biological Psychiatry 46, 13751387.

M El Yacoubi , S Bouali , D Popa , L Naudon , (2003). Behavioral, neurochemical, and electrophysiological characterization of a genetic mouse model of depression. Proceedings of the National Academy of Sciences USA 100, 62276232.

L Groenink , J Van der Gugten , JC Compaan , RA Maes , (1997). Flesinoxan pretreatment differentially affects corticosterone, prolactin and behavioural responses to a flesinoxan challenge. Psychopharmacology 131, 93–100.

N Haddjeri , P Blier , C De Montigny (1998). Long-term antidepressant treatments result in a tonic activation of forebrain 5-HT1A receptors. Journal of Neuroscience 18, 1015010156.

N Haddjeri , C Ortemann , C De Montigny , P Blier (1999). Effect of sustained administration of the 5-HT1A receptor agonist flesinoxan on rat 5-HT neurotransmission. European Neuropsychopharmacology 9, 427440.

SA Julious (2004). Using confidence intervals around individual means to assess statistical significance between two means. Pharmaceutical Statistics 3, 217222.

D Kelder , SB Ross (1992). Long lasting attenuation of 8-OH-DPAT-induced corticosterone secretion after a single injection of a 5-HT1A receptor agonist. Naunyn-Schmiedebergs Archives of Pharmacology 346, 121126.

T Kenakin (2007). Functional selectivity through protean and biased agonism: who steers the ship? Molecular Pharmacology 72, 13931401.

W Koek , B Vacher , C Cosi , M-B Assié , (2001). 5-HT1A receptor activation and antidepressant-like effects: F 13714 has high efficacy and marked antidepressant potential. European Journal of Pharmacology 420, 103112.

L Lemoine , M Verdurand , B Vacher , E Blanc , (2009). Synthesis, fluorine-18 labelling and radiopharmacological evaluation of F15599, a novel 5-HT1A receptor agonist. Journal of Nuclear Medicine 49 (Suppl. 1), 285P.

C Mannoury la Cour , S El Mestikawy , N Hanoun , M Hamon , (2006). Regional differences in the coupling of 5-hydroxytryptamine-1A receptors to G proteins in the rat brain. Molecular Pharmacology 70, 10131021.

GK Matheson , BU Raess , G Tunnicliff (1996). Effects of repeated doses of azapirones on rat brain 5-HT1A receptors and plasma corticosterone levels. General Pharmacology 27, 355361.

MJ Millan , JM Rivet , H Canton , S Le Marouille Girardon , (1993). Induction of hypothermia as a model of 5-hydroxytryptamine1A receptor-mediated activity in the rat: a pharmacological characterization of the actions of novel agonists and antagonists. Journal of Pharmacology and Experimental Therapeutics 264, 13641376.

JM Miller , KG Brennan , TR Ogden , MA Oquendo , (2009). Elevated serotonin 1A binding in remitted major depressive disorder: evidence for a trait biological abnormality. Neuropsychopharmacology 34, 22752284.

MC Miquel , E Doucet , C Boni , S El Mestikawy , (1991). Central serotonin1A receptors – respective distributions of encoding messenger RNA, receptor protein and binding sites by in situ hybridization histochemistry, radioimmunohistochemistry and autoradiographic mapping in the rat brain. Neurochemistry International 19, 453465.

L Naudon , M El Yacoubi , JM Vaugeois , I Leroux-Nicollet , (2002). A chronic treatment with fluoxetine decreases 5-HT1A receptors labeling in mice selected as a genetic model of helplessness. Brain Research 936, 6875.

A Newman-Tancredi , JC Martel , M-B Assié , J Buritova , (2009). Signal transduction and functional selectivity of F15599, a preferential post-synaptic 5-HT1A receptor agonist. British Journal of Pharmacology 156, 338353.

RV Parsey , MA Oquendo , RT Ogden , DM Olvet , (2006). Altered serotonin 1A binding in major depression: a [carbonyl-C-11]WAY100635 positron emission tomography study. Biological Psychiatry 59, 106113.

C Sanchez (2003). Stress-induced vocalisation in adult animals. A valid model of anxiety? European Journal of Pharmacology 463, 133143.

PA Sargent , KH Kjaer , CJ Bench , EA Rabiner , (2000). Brain serotonin1A receptor binding measured by positron emission tomography with [11C]WAY-100635 – effects of depression and antidepressant treatment. Archives of General Psychiatry 57, 174180.

J Savitz , I Lucki , WC Drevets (2009). 5-HT1A receptor function in major depressive disorder. Progress in Neurobiology 88, 1731.

J Shao , D Tu (1995). The Jackknife and Bootstrap. New York: Springer Verlag Inc.

GM Sullivan , RT Ogden , MA Oquendo , JS Kumar , (2009). Positron emission tomography quantification of serotonin-1. A receptor binding in medication-free bipolar depression. Biological Psychiatry 66, 223230.

B Szewczyk , PR Albert , AM Burns , M Czesak , (2009). Gender-specific decrease in NUDR and 5-HT1A receptor proteins in the prefrontal cortex of subjects with major depressive disorder. International Journal of Neuropsychopharmacology 12, 155168.

MD Tricklebank , C Forler , JR Fozard (1984). The involvement of subtypes of the 5-HT1 receptor and of catecholaminergic systems in the behavioural response to 8-hydroxy-2-(di-n-propylamino)tetralin in the rat. European Journal of Pharmacology 106, 271282.

S Wieland , I Lucki (1990). Antidepressant-like activity of 5-HT1A agonists measured with the forced swim test. Psychopharmacology 101, 497504.

Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

The International Journal of Neuropsychopharmacology
  • ISSN: 1461-1457
  • EISSN: 1469-5111
  • URL: /core/journals/the-international-journal-of-neuropsychopharmacology
Please enter your name
Please enter a valid email address
Who would you like to send this to? *